Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
GlaxoSmithKline ( (GSK) ) has shared an update.
GSK plc announced an update regarding its total voting rights and capital for shareholders, as required by the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. As of December 31, 2024, GSK’s issued share capital comprised over 4.3 billion ordinary shares, with approximately 169 million held in Treasury, resulting in a total of over 4.1 billion voting rights. This information is pertinent for shareholders to assess their holdings and any necessary notifications under regulatory guidelines.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a leading global healthcare company headquartered in London, primarily engaged in the development, manufacture, and marketing of pharmaceuticals and healthcare products. The company focuses on innovative medicines, vaccines, and consumer healthcare products, serving a wide range of markets worldwide.
Average Trading Volume: 5,884,947
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $68.79B
For an in-depth examination of GSK stock, go to TipRanks’ Stock Analysis page.
